Duncker Streett & Co. Inc. Sells 119 Shares of Albemarle Co. (NYSE:ALB)

Duncker Streett & Co. Inc. decreased its holdings in shares of Albemarle Co. (NYSE:ALB) by 24.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 364 shares of the specialty chemicals company’s stock after selling 119 shares during the period. Duncker Streett & Co. Inc.’s holdings in Albemarle were worth $53,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in ALB. CENTRAL TRUST Co boosted its position in shares of Albemarle by 3.4% in the 3rd quarter. CENTRAL TRUST Co now owns 1,149 shares of the specialty chemicals company’s stock worth $304,000 after purchasing an additional 38 shares in the last quarter. Covestor Ltd boosted its position in shares of Albemarle by 51.2% in the 1st quarter. Covestor Ltd now owns 130 shares of the specialty chemicals company’s stock worth $29,000 after purchasing an additional 44 shares in the last quarter. McIlrath & Eck LLC boosted its position in shares of Albemarle by 39.0% in the 4th quarter. McIlrath & Eck LLC now owns 164 shares of the specialty chemicals company’s stock worth $36,000 after purchasing an additional 46 shares in the last quarter. Thrivent Financial for Lutherans lifted its position in Albemarle by 1.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 5,212 shares of the specialty chemicals company’s stock valued at $1,378,000 after acquiring an additional 50 shares in the last quarter. Finally, Centaurus Financial Inc. lifted its position in Albemarle by 3.4% in the 1st quarter. Centaurus Financial Inc. now owns 1,593 shares of the specialty chemicals company’s stock valued at $352,000 after acquiring an additional 52 shares in the last quarter. Institutional investors own 92.87% of the company’s stock.

Albemarle Stock Up 0.2 %

Shares of NYSE:ALB opened at $114.39 on Thursday. The company has a current ratio of 1.47, a quick ratio of 0.86 and a debt-to-equity ratio of 0.37. Albemarle Co. has a 12 month low of $106.69 and a 12 month high of $247.44. The company has a 50-day moving average price of $123.17 and a 200 day moving average price of $129.95. The company has a market cap of $13.44 billion, a price-to-earnings ratio of 8.57, a PEG ratio of 2.31 and a beta of 1.62.

Albemarle (NYSE:ALB) last announced its quarterly earnings data on Thursday, February 15th. The specialty chemicals company reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.99 by $0.86. The business had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.18 billion. Albemarle had a net margin of 16.36% and a return on equity of 26.62%. The firm’s quarterly revenue was down 10.1% compared to the same quarter last year. During the same quarter last year, the firm earned $8.62 earnings per share. As a group, equities research analysts predict that Albemarle Co. will post 3.09 earnings per share for the current year.

Albemarle Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 1st. Shareholders of record on Friday, March 15th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.40%. The ex-dividend date of this dividend was Thursday, March 14th. Albemarle’s payout ratio is currently 11.99%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ALB. UBS Group lowered their price objective on Albemarle from $137.00 to $125.00 and set a “neutral” rating on the stock in a research report on Thursday, February 15th. Loop Capital lowered their price objective on Albemarle from $168.00 to $162.00 and set a “buy” rating on the stock in a research report on Friday, March 15th. Bank of America raised Albemarle from a “neutral” rating to a “buy” rating and increased their price target for the company from $137.00 to $156.00 in a report on Wednesday, April 10th. Citigroup increased their price target on Albemarle from $125.00 to $135.00 and gave the company a “neutral” rating in a report on Wednesday, April 10th. Finally, KeyCorp lowered their price target on Albemarle from $178.00 to $159.00 and set an “overweight” rating on the stock in a report on Thursday, March 7th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $175.05.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.